FrancophonIA/ELRC3.0 huggingface dataset:
English: Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection aripiprazole
Slovenian: Abilify Maintena 300 mg prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem aripiprazol
English: Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe aripiprazole
Slovenian: Abilify Maintena 400 mg prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem v napolnjeni injekcijski brizgi aripiprazol
English: When used concomitantly with strong CYP3A4 inhibitors the dose should be reduced to 200 mg (see section 4.5).
Slovenian: Med sočasno uporabo močnih zaviralcev CYP3A4 je treba odmerek zmanjšati na
English: Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe aripiprazole
Slovenian: Abilify Maintena 300 mg prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem v napolnjeni injekcijski brizgi aripiprazol
English: Shake the syringe vigorously for at least 20 seconds to re-suspend prior to injection if the syringe has been left for more than 15 minutes.
Slovenian: Če injekcijske brizge ne uporabite več kot 15 minut po rekonstituciji, jo pred injiciranjem močno stresajte vsaj 20 sekund, da zdravilo ponovno suspendira.
English: Bradykinesia
Slovenian: aripiprazol
English: Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe
Slovenian: Abilify Maintena 300 mg prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem v napolnjeni injekcijski brizgi
English: Jaundice
Slovenian: Viala
English: Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe
Slovenian: Abilify Maintena 400 mg prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem v napolnjeni injekcijski brizgi
English: Photosensitivity reaction Hyperhidrosis
Slovenian: Bolezni kože in podkožja alopecija akne rozacea ekcem izpuščaj fotosenzibilnostna reakcija hiperhidroza
English: The pivotal trial was a 38 week, randomised, double-blind, active-controlled trial designed to establish the efficacy, safety, and tolerability of this medicinal product administered as monthly injections compared to once daily oral aripiprazole tablets 10-30 mg as maintenance treatment in adult patients with schizophrenia.
Slovenian: injiciranega v enkrat mesečnih odmerkih v primerjavi z aripiprazolom v 10-30 mg peroralnih tabletah, danih enkrat dnevno, kot vzdrževalno zdravljenje pri odraslih bolnikih s shizofrenijo.
English: Vomiting
Slovenian: Prolaktin
English: Abilify Maintena comes as a pre-filled syringe.
Slovenian: Zdravilo Abilify Maintena je na voljo v napolnjeni injekcijski brizgi.
English: In clinical trials aripiprazole has not been shown to induce clinically relevant weight gain (see section 4.8).
Slovenian: V kliničnih preskušanjih niso ugotovili, da bi aripiprazol povzročil klinično pomembno povečanje telesne mase
English: • feeling sick
Slovenian: • bolečina v očeh,
English: Powder and solvent for prolonged-release suspension for injection One pre-filled syringe containing powder in the front chamber and solvent in the rear chamber.
Slovenian: Skupno pakiranje: tri enojna pakiranja, vsako pakiranje vsebuje naslednje: Ena napolnjena injekcijska brizga iz stekla tipa I s praškom v sprednji in topilom v zadnji komori.
English: • panic reaction
Slovenian: • povečano zanimanje za spolnost, • panična reakcija,
English: Blood glucose increased Blood glucose decreased Glycosylated haemoglobin increased
Slovenian: Preiskave povišana vrednost kreatinfosfokinaze v krvi zvišana vrednost glukoze v krvi znižana vrednost glukoze v krvi zvišana vrednost glikoziliranega hemoglobina povečan obseg pasu zmanjšana vrednost holesterola v krvi zmanjšana vrednost trigliceridov v krvi nihanje vrednosti glukoze v krvi
English: Description of selected adverse reactions
Slovenian: Opis posameznih neželenih učinkov Reakcije na mestu injiciranja
English: Nausea
Slovenian: Natrij
English: Completed suicide Suicide attempt Pathological gambling Impulse-control disorders Binge eating
Slovenian: Psihiatrične motnje agitacija anksioznost nemir nespečnost misli na samomor psihotične motnje halucinacije blodnje hiperseksualnost panična reakcija depresija čustvena labilnost apatija disforija motnje spanja bruksizem zmanjšan libido sprememba razpoloženja samomor poskus samomora patološko hazardiranje motnje nadzora impulzov kompulzivno prenajedanje kompulzivno nakupovanje poriomanija zivčnost agresija
English: Contents of the pack and other information
Slovenian: Shranjevanje zdravila Abilify Maintena Vsebina pakiranja in dodatne informacije
English: The recommended needle for deltoid administration is a 25 mm (1 inch), 23 gauge hypodermic safety needle; for obese patients, a 38 mm (1.5 inch), 22 gauge hypodermic safety needle should be used.
Slovenian: - ena 3 ml injekcijska brizga za enkratno uporabo s konico Luer Lock, - en nastavek za vialo, - ena 25 mm podkožna varnostna igla velikosti 23 z varnostnim pripomočkom, - ena 38 mm podkožna varnostna igla velikosti 22 z varnostnim pripomočkom, - ena 51 mm podkožna varnostna igla velikosti 21 z varnostnim pripomočkom, - navodila za uporabo injekcijske brizge in igle.
English: It is used for the treatment of:
Slovenian: Uporablja se za zdravljenje:
English: Further information on Mekinist can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Slovenian: Nadaljnje informacije o zdravilu Mekinist so na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Mekinist is available as tablets (0.5 and 2 mg).
Slovenian: Zdravilo Mekinist je na voljo v obliki tablet (0,5 mg in 2 mg).
English: What measures are being taken to ensure the safe and effective use of Mekinist?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Mekinist?
English: The dose of Mekinist is 2 mg once a day taken on an empty stomach (at least 1 hour before or 2 hours after a meal) and at around the same time every day.
Slovenian: Odmerek zdravila Mekinist je 2 mg, jemlje pa se enkrat na dan na prazen želodec (vsaj eno uro pred obrokom ali dve uri po obroku) ter vsak dan ob približno istem času.
English: Other information about Mekinist
Slovenian: Druge informacije o zdravilu Mekinist
English: Mekinist received a marketing authorisation valid throughout the EU on 30 June 2014.
Slovenian: Za zdravilo Mekinist je bilo 30. junija 2014 izdano dovoljenje za promet, veljavno po vsej EU.
English: As for all medicines, data on the use of Mekinist are continuously monitored.
Slovenian: Tako kot za vsako zdravilo se tudi podatki o uporabi zdravila Mekinist stalno spremljajo.
English: Treatment with Mekinist must be started and supervised by a doctor experienced in the use of cancer medicines.
Slovenian: Zdravljenje z zdravilom Mekinist mora uvesti in nadzorovati zdravnik, ki ima izkušnje z uporabo zdravil za zdravljenje raka.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Mekinist have been included in the summary of product characteristics and the package leaflet.
Slovenian: Priporočila in previdnostni ukrepi, ki jih morajo za varno in učinkovito uporabo zdravila Mekinist upoštevati zdravstveni delavci in bolniki, so vključeni v povzetek glavnih značilnosti zdravila in navodilo za uporabo.
English: An overview of Mekinist and why it is authorised in the EU
Slovenian: Pregled zdravila Mekinist in zakaj je odobreno v EU
English: Why is Mekinist authorised in the EU?
Slovenian: Zakaj je bilo zdravilo Mekinist odobreno v EU?
English: What benefits of Mekinist have been shown in studies?
Slovenian: Kakšne koristi zdravila Mekinist so se pokazale v študijah?
English: What are the risks associated with Mekinist?
Slovenian: Kakšna tveganja so povezana z zdravilom Mekinist?
English: The use of Mekinist and dabrafenib led to a response in over 60% of the patients, compared with 23% of patients using dabrafenib alone.
Slovenian: Z uporabo zdravila Mekinist in dabrafeniba je prišlo do odziva pri več kot 60 % bolnikov v primerjavi s 23 % bolnikov, ki so jemali samo dabrafenib.
English: Mekinist's side effects were considered acceptable and manageable with appropriate measures.
Slovenian: Neželeni učinki zdravila Mekinist veljajo za sprejemljive in jih je mogoče obvladovati z ustreznimi ukrepi.
English: Side effects reported with Mekinist are carefully evaluated and any necessary action taken to protect patients.
Slovenian: Neželeni učinki, o katerih so poročali pri zdravilu Mekinist, se skrbno ovrednotijo in po potrebi se sprejmejo ukrepi za zaščito bolnikov.
English: This was based on a main study involving 322 patients who received either Mekinist or the comparator medicine and which measured how long patients lived until their disease got worse.
Slovenian: To je temeljilo na eni glavni študiji, ki je vključevala 322 bolnikov, ki so prejemali bodisi zdravilo Mekinist bodisi primerjalno zdravilo, v študiji pa so merili čas preživetja bolnikov do poslabšanja bolezni.
English: Some 40% of patients treated with the combination either died or had their disease come back after an average of about 3.5 years compared with 59% of patients receiving placebo.
Slovenian: Približno 40 % bolnikov, zdravljenih s kombinacijo učinkovin, je po treh letih in pol bodisi umrlo ali se jim je bolezen ponovila; med bolniki, ki so prejemali placebo, pa je bilo takih 59 %.
English: What is Mekinist and what is it used for?
Slovenian: Kaj je zdravilo Mekinist in za kaj se uporablja?
English: For more information about using Mekinist, see the package leaflet or contact your doctor or pharmacist.
Slovenian: Za več informacij glede uporabe zdravila Mekinist glejte navodilo za uporabo ali se posvetujte z zdravnikom ali farmacevtom.
English: The European Medicines Agency decided that Mekinist's benefits in cancers that carry the BRAF V600 mutation are greater than its risks and it can be authorised for use in the EU.
Slovenian: Evropska agencija za zdravila je zaključila, da so koristi zdravila Mekinist pri zdravljenju raka z mutacijo BRAF V600 večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
English: Mekinist can be continued for as long as the patient benefits from it. After surgery for advanced melanoma, treatment is normally continued for 12 months unless the disease comes back.
Slovenian: Po kirurškem posegu zaradi napredovalega melanoma se zdravljenje običajno nadaljuje 12 mesecev, razen če se bolezen ponovi.
English: The most common side effects with Mekinist (which may affect more than 1 in 5 people) are rash, diarrhoea, tiredness, peripheral oedema (swelling, especially of ankles and feet), nausea and acneiform dermatitis (acne-like inflammation of the skin).
Slovenian: Najpogostejši neželeni učinki zdravila Mekinist (ki se lahko pojavijo pri več kot 1 bolniku od 5) so izpuščaj, driska, utrujenost, periferni edem (otekanje, zlasti stopal in gležnjev), navzeja in akneiformni dermatitis (aknam podobno vnetje kože).
English: In melanoma and non-small cell lung cancer with the BRAF V600 mutation, an abnormal form of the protein BRAF is present, which switches on another protein called MEK involved in stimulating cell division.
Slovenian: Pri melanomu in nedrobnoceličnem pljučnem raku z mutacijo BRAF V600 je prisotna nenormalna oblika beljakovine BRAF, ki aktivira drugo beljakovino, imenovano MEK, ki sodeluje pri spodbujanju delitve celic.
English: When Mekinist is taken in combination with dabrafenib the most common side effects (which may affect more than 1 in 5 people) are fever, tiredness, nausea, chills, headache, diarrhoea, vomiting, joint pain and rash.
Slovenian: Kadar se zdravilo Mekinist jemlje v kombinaciji z dabrafenibom, so najpogostejši neželeni učinki (ki se lahko pojavijo pri več kot 1 bolniku od 5) povišana telesna temperatura, utrujenost, navzeja, mrzlica, glavobol, driska, bruhanje, bolečine v sklepih in izpuščaj.
English: In an additional study Mekinist did not show any benefit when given to patients who did not respond to previous treatment with another cancer medicine that blocked BRAF.
Slovenian: V dodatni študiji zdravila Mekinist, v kateri so ga dajali bolnikom, ki se niso odzvali na predhodno zdravljenje z drugim zdravilom, ki zavira beljakovino BRAF, niso opazili nobenih koristi.
English: Mekinist is a cancer medicine used to treat adults whose cancer cells have a specific genetic mutation (change) in their genes called 'BRAF V600'.
Slovenian: Zdravilo Mekinist je zdravilo za zdravljenje raka, ki se uporablja za zdravljenje odraslih, katerih rakave celice imajo posebno gensko mutacijo (spremembo), imenovano „BRAF V600“.
English: The Agency considered that Mekinist when used alone or in combination with dabrafenib had shown a clinically relevant benefit in patients with non-small cell lung cancer or with melanoma that had spread or could not be removed surgically.
Slovenian: Ocenila je, da je zdravilo Mekinist, kadar se je uporabljal samostojno ali v kombinaciji z dabrafenibom, izkazalo klinično pomembne koristi pri bolnikih z drobnoceličnim pljučnim rakom ali melanomom, ki se je razširil ali ga ni mogoče kirurško odstraniti.
English: Patients given the combination lived on average 25.6 months versus 18 months with vemurafenib.
Slovenian: Bolniki, ki so prejemali kombinacijo učinkovin, so povprečno živeli 25,6 meseca v primerjavi z 18 meseci pri jemanju vemurafeniba.
English: Two additional studies on melanoma that had spread to other parts of the body or could not be removed surgically looked at using the combination of Mekinist and dabrafenib.
Slovenian: V dveh dodatnih študijah pri melanomu, ki se je razširil na druge dele telesa ali ga ni bilo mogoče kirurško odstraniti, so proučevali uporabo kombinacije zdravila Mekinist in dabrafeniba.
English: Patients taking Mekinist lived on average for 4.8 months before their disease getting worse, compared with 1.5 months for patients given dacarbazine or paclitaxel.
Slovenian: Bolniki, ki so jemali zdravilo Mekinist, so živeli povprečno 4,8 meseca, preden se jim je bolezen poslabšala, bolniki, ki so jemali dakarbazin ali paklitaksel, pa 1,5 meseca.
English: This leads cancers to develop by allowing uncontrolled division of cells.
Slovenian: To privede do nenadzorovane delitve celic in s tem razvoja raka.
English: In a study involving 870 patients with stage III melanoma that had been removed surgically, the combination of Mekinist and dabrafenib given for 1 year was compared with placebo (a dummy treatment).
Slovenian: V študiji, ki je vključevala 870 bolnikov z melanomom v III. stadiju, ki so ga kirurško odstranili, so kombinacijo zdravila Mekinist in dabrafeniba, ki so jo bolnikom dajali eno leto, primerjali s placebom (zdravilom brez učinkovine).
English: The active substance in Mekinist, trametinib, works by blocking MEK and by preventing its activation by BRAF, thereby slowing down the growth and spread of the cancer.
Slovenian: Učinkovina v zdravilu Mekinist, trametinib, deluje tako, da neposredno zavira beljakovino MEK, beljakovini BRAF pa prepreči, da bi jo aktivirala, s čimer upočasni rast in širjenje raka.
English: Mekinist is used on its own or in combination with another cancer medicine, dabrafenib;
Slovenian: Zdravilo Mekinist se uporablja samostojno ali v kombinaciji z drugim zdravilom za zdravljenje raka, dabrafenibom;
English: For the full list of side effects and restrictions of Mekinist, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov in omejitev pri uporabi zdravila Mekinist glejte navodilo za uporabo.
English: In one study, 423 patients were given either the combination or dabrafenib alone.
Slovenian: V eni študiji je 423 bolnikov prejelo bodisi kombinacijo obeh učinkovin bodisi samo dabrafenib.
English: Patients given the combination lived for 11 months without their disease worsening compared with 8.8 months for those given dabrafenib alone.
Slovenian: Bolniki, ki so prejemali kombinacijo učinkovin, so brez poslabšanja bolezni živeli 11 mesecev, bolniki, ki so prejemali samo dabrafenib, pa 8,8 meseca.
English: In a second study involving 704 patients, Mekinist with dabrafenib was compared with another medicine for melanoma, vemurafenib.
Slovenian: V drugi študiji, ki je vključevala 704 bolnike, so zdravilo Mekinist v kombinaciji z dabrafenibom primerjali z drugim zdravilom za zdravljenje melanoma, vemurafenibom.
English: In one main study, 171 patients with non-small cell lung cancer received either dabrafenib combined with Mekinist or dabrafenib alone.
Slovenian: V eni glavni študiji je 171 bolnikov z nedrobnoceličnim pljučnim rakom prejemalo bodisi dabrafenib v kombinaciji z zdravilom Mekinist bodisi samo dabrafenib.
English: How does Mekinist work?
Slovenian: Kako zdravilo Mekinist deluje?
English: Mekinist has been studied in patients whose cancer had the BRAF V600 mutation.
Slovenian: Zdravilo Mekinist so proučevali pri bolnikih, katerih rakave celice so imele mutacijo BRAF V600.
English: Mekinist contains the active substance trametinib.
Slovenian: Zdravilo Mekinist vsebuje učinkovino trametinib.
English: How is Mekinist used?
Slovenian: Kako se zdravilo Mekinist uporablja?
English: It is used in combination with dabrafenib.
Slovenian: Zdravilo Mekinist se uporablja v kombinaciji z dabrafenibom.
English: Mekinist was more effective than the cancer medicines dacarbazine or paclitaxel at controlling melanoma that had spread to other parts of the body or could not be removed surgically.
Slovenian: Zdravilo Mekinist je bilo pri nadziranju melanoma, ki se je razširil na druge dele telesa ali ga ni bilo mogoče kirurško odstraniti, učinkovitejše od drugih zdravil za zdravljenje raka, dakarbazina ali paklitaksela.
English: • advanced (stage III) melanoma after surgery for it. Mekinist is used in combination with dabrafenib;
Slovenian: • napredovalega melanoma (v III. stadiju) po prestanem kirurškem posegu.
English: Milk: 2.5 days
Slovenian: Mleko: 2,5 dni
English: Re-examination of the opinion
Slovenian: Ponovna preučitev mnenja
English: Or variations of that name as referred to in Annex I
Slovenian: Ali različic tega imena, kot so navedene v Dodatku I.
English: Meat and offal: Cattle: 58 days Pigs: 35 days
Slovenian: Meso in drobovina: govedo: 58 dni prašiči: 35 dni
English: Assessment of new data further to the request for re-consideration by the European Commission
Slovenian: Ocena novih podatkov, predloženih po zahtevi za ponovno preučitev s strani Evropske komisije
English: Marketing Authorisation pending 2 Reference Member State for the Mutual recognition Procedure
Slovenian: 1 Odobritev dovoljenja za promet v teku 2 Referenčna država članica za postopek medsebojnega priznavanja
English: It was evident that penicillin residues have caused allergic reactions in consumers and that some of these reactions have been serious.
Slovenian: Očitno je bilo, da so ostanki penicilina povzročili alergijske reakcije pri potrošnikih in da so bile nekatere teh reakcij resne.
English: The CVMP concluded that this was not scientifically justified.
Slovenian: CVMP je menil, da to ni bilo znanstveno utemeljeno.
English: However an ADI for penicillins was not established.
Slovenian: Kljub temu ADI za peniciline ni bil določen.
English: 1ere Avenue 2056 M Lid 06516 Carros Cedex France
Slovenian: 1ere Avenue 2056 M Lid FR-06516 Carros Cedex
English: At slaughter, the left (first) injection site was taken for local tolerance assessment.
Slovenian: Pri zakolu so levo (prvo) mesto injiciranja vzeli za oceno lokalne tolerance.
English: Two intramuscular injections at 48 hours interval
Slovenian: Dve injekciji intramuskularno z vmesnim intervalom 48 ur
English: Reports of further cases, which were not available to JECFA, had also been reported in the published literature.
Slovenian: Poročila o dodatnih primerih, ki JEFCA niso bila na razpolago, so bila prav tako navedena v objavljeni literaturi.
English: Invented name
Slovenian: Izmišljeno ime izdelka
English: Whilst the finding of amoxicillin concentrations above the MRL at two time points following the apparent clear result at 14 days could be an artefact, it could equally be argued that it was the results at 14 days that proved unreliable.
Slovenian: Medtem ko bi najdene koncentracije amoksicilina nad MRL v dveh časovnih točkah, ki sta sledili očitno čistem rezultatu po 14 dneh, lahko bile artefakt, pa je možno trditi tudi, da so rezultati dobljeni po 14 dneh tisti, ki so nezanesljivi.
English: In addition the analytical method for the determination of the residues was not sufficiently validated.
Slovenian: Prav tako analitična metoda za določanje ostankov ni bila zadovoljivo potrjena.
English: Amoxicillin All food producing species
Slovenian: Amoksicilin Vse vrste za proizvodnjo živil
English: The MAH further argued that the method used was probably not robust enough and cited a recent publication that mentions the need for deproteinization steps to improve method recovery.
Slovenian: MAH je nadalje trdil, da uporabljena metoda verjetno ni bila dovolj robustna in citiral nedavno publikacijo, v kateri je omenjeno, da so za izboljšanje metode obnovljivosti potrebni deproteinizacijski koraki.
English: The first injection was given in the muscles of the left side of the neck, the second injection was given 48 hours later in the right side of the neck.
Slovenian: Prvi odmerek je bil injiciran v mišice leve strani vratu, druga injekcija je bila dana 48 ur kasneje na desno stran vratu.
English: The CVMP concluded that the statistical method could not be used based on the data of the new study provided.
Slovenian: CVMP je zaključil, da na podlagi predloženih podatkov iz nove študije ni mogoče uporabiti statistične metode.
English: Only residues at the injection sites were investigated.
Slovenian: Preučevani so bili le ostanki na mestih injiciranja.
English: In setting maximum residue limits (MRLs) for the penicillins, the CVMP adopted the same approach as the Joint FAO/WHO Expert Committee on Food Additives (JECFA).
Slovenian: Pri določanju najvišjih vrednosti ostankov (MRL) za peniciline, je CVMP sprejel enak pristop kot Skupni strokovni odbor FAO/WHO za aditive za živila (JECFA).
English: In addition the data were derived from animals weighting approximately 200 kg and receiving only one injection per dose administration, which are not necessarily representative of heavier animals requiring multiple injections.
Slovenian: Poleg tega so bili podatki vzeti pri živalih s telesno težo približno 200 kg, ki so prejele le eno injekcijo na dani odmerek in niso nujno reprezentativne za težje živali, ki potrebujejo več injekcij.
English: LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS, ANIMAL SPECIES, FREQUENCY AND ROUTES OF ADMINISTRATION, RECOMMENDED DOSES, WITHDRAWAL PERIODS AND MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES CONCERNED BY THE REFERRAL
Slovenian: SEZNAM IMEN, FARMACEVTSKIH OBLIK, JAKOSTI, ŽIVALSKIH VRST, POGOSTOSTI IN NAČINOV UPORABE ZDRAVILA, PRIPOROČENIH ODMERKOV, KARENCE IN IMETNIKOV DOVOLJENJA ZA PROMET V DRŽAVAH ČLANICAH, NA KATERE SE NAPOTITVENI POSTOPEK NANAŠA
English: Therefore withdrawal periods for cattle and pigs could not be recommended.
Slovenian: Posledično karenc za govedo in prašiče ni mogoče priporočiti.
English: Assessment of residue depletion studies initially submitted
Slovenian: Ocena prvotno predloženih raziskav izločanja ostankov
English: On this basis MRLs for amoxicillin and other penicillins were proposed by the CVMP, and amoxicillin is currently entered in Annex I of Council Regulation (EEC) No 2377/90, in accordance with the following table:
Slovenian: Na podlagi tega je CVMP predlagal MRL za amoksicilin in druge peniciline, amoksicilin pa je trenutno uvrščen v Prilogo I Uredbe Sveta (EGS) št. 2377/90, v skladu z naslednjo preglednico: